By Staff Reporter Results from a newly published study highlight the growing spread of drug resistance across 14 African countries, underscoring the urgent need to strengthen laboratory testing, data systems, and health planning to tackle hard-to-treat infections. The study, known as the Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP), is the largest of its kind ever conducted in Africa. It was led by a coalition including the Africa Centres for Disease Control and Prevention (Africa CDC), the African Society for Laboratory Medicine (ASLM), One Health Trust, and other regional partners.…
Read MoreTag: Ethiopia
Zimbabwe Joins Rollout of First-Ever Oral Treatment for Deadly Sleeping Sickness
By Michael Gwarisa Zimbabwe is among five African countries that have started administering the world’s first all-oral treatment for Trypanosoma brucei rhodesiense sleeping sickness—a rare but deadly disease that has long affected communities in East and Southern Africa. The development marks a turning point in the fight against this neglected tropical disease, especially in endemic regions like Zimbabwe, where tsetse fly infestations remain a concern. The new drug, Fexinidazole Winthrop, is now being offered free of charge in specialized treatment centres in Zimbabwe, Malawi, Ethiopia, Tanzania, and Zambia. Its approval…
Read More